Informações:
Falhas:
ID
28972
Descrição
Study part: Follow- up Contact Month 3. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.
Palavras-chave
Versões (1)
- 18/02/2018 18/02/2018 -
Titular dos direitos
Roche
Transferido a
18 de fevereiro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Follow- up Contact Month 3 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g
Follow- up Contact Month 3
- StudyEvent: ODM
Similar models
Follow- up Contact Month 3
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
text
C1320303 (UMLS CUI [1])
follow-up visit
Item
Was the subject contacted 2 days after study treatment?
boolean
C0589121 (UMLS CUI [1])
Date of Contact
Item
Date of Contact:
date
C0805839 (UMLS CUI [1])
post treatment antibodies
Item
Has the subject been taking the prescribed self-administered post-injection antimicrobials?
boolean
C2709088 (UMLS CUI [1,1])
C0003241 (UMLS CUI [1,2])
C0003241 (UMLS CUI [1,2])
Low Vision
Item
Decrease in Vision- Has the subject experienced a decrease in vision in the study eye since treatment?
boolean
C0042798 (UMLS CUI [1])
Eye Pain
Item
Eye Pain- Has the subject had any eye pain in the study eye since treatment?
boolean
C0151827 (UMLS CUI [1])
eye redness
Item
Unusual Redness- Has the subject had any new or unusual redness in the study eye (other than localized redness at the injection site) since treatment?
boolean
C0235267 (UMLS CUI [1])
Ocular Symptoms
Item
New Ocular Symptoms- Has the subject experienced any other new ocular symptoms in the study eye since treatment?
boolean
C0586406 (UMLS CUI [1])
Safety Assessment Visit
Item
Safety Assessment Visit- Was the subject asked to return to the clinic for a safety assessment visit?
boolean
C0589121 (UMLS CUI [1,1])
C0549076 (UMLS CUI [1,2])
C0549076 (UMLS CUI [1,2])